Sharing Our Expertise

Over the last several decades, the global pharmaceutical industry has experienced a significant shift...

The 505(b)(2) regulatory pathway is an increasingly popular method of getting drug approval – and one...

 "Many people think all we do is mix things to make a product." - Deepak Thassu, LGM's Vice President...

The pandemic has left a substantial impact on our world that will be felt for years to come. It has led...

The main goal for any drug company is achieving a speedy path to market. While many obstacles threaten...

Although solid dosage forms like tablets and capsules continue to dominate the global pharmaceutical...